Substance / Medication

Ciprofloxacin hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

38 trials linked to this intervention

38
Total Trials
9
Recruiting
6
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach.
Karimi Keyhaneh, Pallagi Edina, Szabó-Révész Piroska et al. · Drug Des Devel Ther · 2016
PMID: 27784991ObservationalFull text (PMC)
Spectrophotometric and chemometric methods for determination of imipenem, ciprofloxacin hydrochloride, dexamethasone sodium phosphate, paracetamol and cilastatin sodium in human urine.
El-Kosasy A M, Abdel-Aziz Omar, Magdy N et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2016
PMID: 26709018Observational
Low molecular mass chitosan as carrier for a hydrodynamically balanced system for sustained delivery of ciprofloxacin hydrochloride.
Verma Anurag, Bansal Ashok K, Ghosh Amitava et al. · Acta Pharm · 2012
PMID: 22750821Observational
Validated spectrophotometric methods for the simultaneous determination of ciprofloxacin hydrochloride and metronidazole in tablets.
Mahrouse Marianne Alphonse, Elkady Ehab Farouk · Chem Pharm Bull (Tokyo) · 2011
PMID: 22130371Observational
Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery.
Jain Dharmendra, Banerjee R · J Biomed Mater Res B Appl Biomater · 2008
PMID: 18098198Observational
Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
Mansour Mai, Mansour Samar, Mortada Nahed D et al. · Drug Dev Ind Pharm · 2008
PMID: 18612913Observational
Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture.
Egerbacher M, Edinger J, Tschulenk W · Am J Vet Res · 2001
PMID: 11341389Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ciprofloxacin hydrochloride (substance)
SNOMED CT
20450009
UMLS CUI
C0282104

Clinical Data

This intervention maps to 25 entities in the Healos knowledge graph.

20
Conditions
2
Biomarkers
2
Specialists
0
Symptoms
38
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Ciprofloxacin hydrochloride — Conditions, Biomarkers & Specialists | Healos | Healos